Publication date: 16 May 2017
Source:Immunity, Volume 46, Issue 5
Author(s): Jinal N. Bhiman, Penny L. Moore
An HIV vaccine that elicits broadly neutralizing antibodies, which often have unusual structural features, has not yet been developed. In Immunity this month, Cale et al., 2017 describe how a new mode of binding allows a conventional antibody to infiltrate HIV's armor.
Teaser
An HIV vaccine that elicits broadly neutralizing antibodies, which often have unusual structural features, has not yet been developed. In Immunity this month, Cale et al., 2017 describe how a new mode of binding allows a conventional antibody to infiltrate HIV's armor.http://ift.tt/2pHYFDR
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου